Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle maturation (GO:0016188) | 4.61822336 |
2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.55476288 |
3 | regulation of cholesterol homeostasis (GO:2000188) | 4.21777165 |
4 | neuronal action potential propagation (GO:0019227) | 4.13176117 |
5 | locomotory exploration behavior (GO:0035641) | 4.10732657 |
6 | glutamate secretion (GO:0014047) | 4.00275287 |
7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.98073682 |
8 | regulation of synapse maturation (GO:0090128) | 3.95234989 |
9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.82709115 |
10 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.74678512 |
11 | regulation of synapse structural plasticity (GO:0051823) | 3.74513075 |
12 | vocalization behavior (GO:0071625) | 3.73164212 |
13 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.72450594 |
14 | synaptic vesicle exocytosis (GO:0016079) | 3.66302221 |
15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.66014378 |
16 | negative regulation of fibrinolysis (GO:0051918) | 3.62936808 |
17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.60310878 |
18 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.57922785 |
19 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.57472691 |
20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.56088743 |
21 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.48540524 |
22 | protein carboxylation (GO:0018214) | 3.48508633 |
23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.48508633 |
24 | cell communication by electrical coupling (GO:0010644) | 3.45969059 |
25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.42469609 |
26 | activation of protein kinase A activity (GO:0034199) | 3.42120242 |
27 | regulation of synaptic vesicle transport (GO:1902803) | 3.40003690 |
28 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.36109676 |
29 | regulation of ARF protein signal transduction (GO:0032012) | 3.36094144 |
30 | neurotransmitter secretion (GO:0007269) | 3.34991595 |
31 | intestinal cholesterol absorption (GO:0030299) | 3.33842360 |
32 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.32830829 |
33 | cerebellar granule cell differentiation (GO:0021707) | 3.31222359 |
34 | plasma membrane repair (GO:0001778) | 3.28607189 |
35 | carnitine shuttle (GO:0006853) | 3.24508967 |
36 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.21581610 |
37 | gamma-aminobutyric acid transport (GO:0015812) | 3.20406152 |
38 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.20005360 |
39 | cellular sodium ion homeostasis (GO:0006883) | 3.19046575 |
40 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.17983188 |
41 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.16418994 |
42 | regulation of fibrinolysis (GO:0051917) | 3.15800789 |
43 | protein-lipid complex assembly (GO:0065005) | 3.15373794 |
44 | cell communication involved in cardiac conduction (GO:0086065) | 3.14883954 |
45 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.12769326 |
46 | protein localization to synapse (GO:0035418) | 3.11997061 |
47 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.11309449 |
48 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.11100157 |
49 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.10262631 |
50 | sodium ion export (GO:0071436) | 3.09696905 |
51 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.09479063 |
52 | exploration behavior (GO:0035640) | 3.07475405 |
53 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.07472352 |
54 | creatine metabolic process (GO:0006600) | 3.07132152 |
55 | neuromuscular process controlling posture (GO:0050884) | 3.04589822 |
56 | lung epithelium development (GO:0060428) | 3.03261717 |
57 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.02763110 |
58 | layer formation in cerebral cortex (GO:0021819) | 3.02444285 |
59 | proline transport (GO:0015824) | 3.02196855 |
60 | aspartate family amino acid catabolic process (GO:0009068) | 3.00542827 |
61 | fatty acid transmembrane transport (GO:1902001) | 2.98374484 |
62 | regulation of membrane repolarization (GO:0060306) | 2.97731435 |
63 | membrane depolarization during action potential (GO:0086010) | 2.97690949 |
64 | plasma lipoprotein particle assembly (GO:0034377) | 2.97097065 |
65 | cellular potassium ion homeostasis (GO:0030007) | 2.96904949 |
66 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.96876576 |
67 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.94962061 |
68 | 2-oxoglutarate metabolic process (GO:0006103) | 2.92508031 |
69 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.91748264 |
70 | lysine catabolic process (GO:0006554) | 2.89449762 |
71 | lysine metabolic process (GO:0006553) | 2.89449762 |
72 | glycine transport (GO:0015816) | 2.88558214 |
73 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.83845389 |
74 | L-phenylalanine metabolic process (GO:0006558) | 2.82358062 |
75 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.82358062 |
76 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.81230324 |
77 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.81230324 |
78 | neuromuscular process controlling balance (GO:0050885) | 2.80528111 |
79 | cholesterol efflux (GO:0033344) | 2.80396810 |
80 | diacylglycerol metabolic process (GO:0046339) | 2.79993875 |
81 | dendritic spine morphogenesis (GO:0060997) | 2.78744275 |
82 | dicarboxylic acid catabolic process (GO:0043649) | 2.78621795 |
83 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.78069075 |
84 | L-phenylalanine catabolic process (GO:0006559) | 2.78069075 |
85 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.77626378 |
86 | regulation of protein activation cascade (GO:2000257) | 2.77585793 |
87 | cardiac muscle contraction (GO:0060048) | 2.76385633 |
88 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.75021537 |
89 | alanine transport (GO:0032328) | 2.73847802 |
90 | cellular ketone body metabolic process (GO:0046950) | 2.73305144 |
91 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.72565259 |
92 | cell migration in hindbrain (GO:0021535) | 2.72436313 |
93 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.72081912 |
94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.72081912 |
95 | NADH metabolic process (GO:0006734) | 2.71704715 |
96 | tricarboxylic acid cycle (GO:0006099) | 2.71365216 |
97 | regulation of complement activation (GO:0030449) | 2.71265648 |
98 | regulation of bile acid biosynthetic process (GO:0070857) | 2.70725107 |
99 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.70111316 |
100 | regulation of apoptotic cell clearance (GO:2000425) | 2.69233166 |
101 | synaptic transmission, glutamatergic (GO:0035249) | 2.68847450 |
102 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.68808492 |
103 | regulation of cell communication by electrical coupling (GO:0010649) | 2.68399641 |
104 | potassium ion import (GO:0010107) | 2.67790651 |
105 | proline metabolic process (GO:0006560) | 2.67452485 |
106 | glutamate metabolic process (GO:0006536) | 2.67407813 |
107 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.66631525 |
108 | regulation of cholesterol metabolic process (GO:0090181) | 2.64004390 |
109 | positive regulation of sodium ion transport (GO:0010765) | 2.62881454 |
110 | regulation of extracellular matrix disassembly (GO:0010715) | 2.62125641 |
111 | alpha-linolenic acid metabolic process (GO:0036109) | 2.60633675 |
112 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.59742121 |
113 | regulation of neurotransmitter levels (GO:0001505) | 2.59577876 |
114 | regulation of cholesterol esterification (GO:0010872) | 2.57853438 |
115 | neuron cell-cell adhesion (GO:0007158) | 2.57552426 |
116 | neurotransmitter transport (GO:0006836) | 2.57134512 |
117 | positive regulation of membrane potential (GO:0045838) | 2.56488872 |
118 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.56257154 |
119 | long-term memory (GO:0007616) | 2.56244481 |
120 | low-density lipoprotein particle clearance (GO:0034383) | 2.56206551 |
121 | potassium ion homeostasis (GO:0055075) | 2.56159594 |
122 | focal adhesion assembly (GO:0048041) | 2.56086772 |
123 | cell-substrate adherens junction assembly (GO:0007045) | 2.56086772 |
124 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.54577933 |
125 | regulation of ARF GTPase activity (GO:0032312) | 2.53943298 |
126 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.52628472 |
127 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.52206246 |
128 | positive regulation of dendritic spine development (GO:0060999) | 2.51335920 |
129 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.51243858 |
130 | protein-lipid complex subunit organization (GO:0071825) | 2.50781158 |
131 | glycogen catabolic process (GO:0005980) | 2.50515114 |
132 | neuron-neuron synaptic transmission (GO:0007270) | 2.49802323 |
133 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.48655830 |
134 | cell volume homeostasis (GO:0006884) | 2.48627576 |
135 | positive regulation of extracellular matrix organization (GO:1903055) | 2.48587265 |
136 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.48470307 |
137 | protein-lipid complex remodeling (GO:0034368) | 2.48401162 |
138 | macromolecular complex remodeling (GO:0034367) | 2.48401162 |
139 | plasma lipoprotein particle remodeling (GO:0034369) | 2.48401162 |
140 | positive regulation of synapse maturation (GO:0090129) | 2.48392673 |
141 | regulation of cofactor metabolic process (GO:0051193) | 2.47273905 |
142 | regulation of coenzyme metabolic process (GO:0051196) | 2.47273905 |
143 | regulation of synaptic plasticity (GO:0048167) | 2.47015720 |
144 | amino acid import (GO:0043090) | 2.46787590 |
145 | regulation of plasminogen activation (GO:0010755) | 2.46127621 |
146 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.44821367 |
147 | axon ensheathment in central nervous system (GO:0032291) | 2.44537566 |
148 | central nervous system myelination (GO:0022010) | 2.44537566 |
149 | oxaloacetate metabolic process (GO:0006107) | 2.44311258 |
150 | adherens junction assembly (GO:0034333) | 2.42843484 |
151 | negative regulation of cholesterol transport (GO:0032375) | 2.42190804 |
152 | negative regulation of sterol transport (GO:0032372) | 2.42190804 |
153 | negative regulation of fatty acid transport (GO:2000192) | 2.42136224 |
154 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.39315972 |
155 | mannose metabolic process (GO:0006013) | 2.39069055 |
156 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.38846220 |
157 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.37626744 |
158 | plasma lipoprotein particle organization (GO:0071827) | 2.37180740 |
159 | macroautophagy (GO:0016236) | 2.36582135 |
160 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.35110034 |
161 | regulation of extracellular matrix organization (GO:1903053) | 2.34475486 |
162 | neuronal ion channel clustering (GO:0045161) | 2.33903366 |
163 | L-amino acid import (GO:0043092) | 2.33538596 |
164 | low-density lipoprotein particle remodeling (GO:0034374) | 2.32139928 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.80193094 |
2 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.60296191 |
3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.84782494 |
4 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.84281437 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.79616699 |
6 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.59818858 |
7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.49052882 |
8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.42490946 |
9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.41787334 |
10 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.37430093 |
11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.36440523 |
12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.30011320 |
13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.27765875 |
14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.26935576 |
15 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.25886471 |
16 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.25841447 |
17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.21612959 |
18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.21086336 |
19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.21086336 |
20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.16514850 |
21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.11503853 |
22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.10192554 |
23 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.05162817 |
24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.97403233 |
25 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.95884254 |
26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95759860 |
27 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.93142654 |
28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.90611801 |
29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.86358874 |
30 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.85571171 |
31 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.84303547 |
32 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.82527292 |
33 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.80162877 |
34 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.77145890 |
35 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.76925230 |
36 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.75315384 |
37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.74983565 |
38 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.71870159 |
39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.64166360 |
40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.62479497 |
41 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59019433 |
42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58887008 |
43 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.58807173 |
44 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.55164001 |
45 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.55063805 |
46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.54894154 |
47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.54198087 |
48 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.54102655 |
49 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.50892949 |
50 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.50796994 |
51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.48620511 |
52 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.48242320 |
53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45950260 |
54 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.45520592 |
55 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.45046658 |
56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.38835909 |
57 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.38144462 |
58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37437763 |
59 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.35844967 |
60 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.35322672 |
61 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34276048 |
62 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.30807737 |
63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29963513 |
64 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24650421 |
65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24025104 |
66 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.23718401 |
67 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.23131063 |
68 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21862690 |
69 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21723653 |
70 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.21412973 |
71 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.18801653 |
72 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18418122 |
73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17308321 |
74 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17302156 |
75 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16367252 |
76 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15462395 |
77 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14708088 |
78 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.13735407 |
79 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 1.12458411 |
80 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.11942284 |
81 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.11094364 |
82 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.10602794 |
83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10536867 |
84 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09736868 |
85 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.08880674 |
86 | * MYC_22102868_ChIP-Seq_BL_Human | 1.08873631 |
87 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08556379 |
88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07326747 |
89 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07150060 |
90 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06444830 |
91 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.06191840 |
92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06008685 |
93 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05904972 |
94 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04191081 |
95 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02400945 |
96 | AR_19668381_ChIP-Seq_PC3_Human | 1.02197682 |
97 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01710571 |
98 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.01324286 |
99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00828914 |
100 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00415851 |
101 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00323438 |
102 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.99528842 |
103 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99175819 |
104 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98795784 |
105 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98769933 |
106 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.98665411 |
107 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96663685 |
108 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95074669 |
109 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.94643837 |
110 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94635604 |
111 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94163100 |
112 | P68_20966046_ChIP-Seq_HELA_Human | 0.93823559 |
113 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.91721514 |
114 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.91520736 |
115 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.91079639 |
116 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89766703 |
117 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.87606421 |
118 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87099466 |
119 | SA1_27219007_Chip-Seq_Bcells_Human | 0.86561635 |
120 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.86546639 |
121 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85925049 |
122 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.84401371 |
123 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.84401371 |
124 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.84367273 |
125 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84076840 |
126 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83462382 |
127 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.80932144 |
128 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.80924177 |
129 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.80624098 |
130 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.79653774 |
131 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.77503985 |
132 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.77254703 |
133 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.76816084 |
134 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.76713212 |
135 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.74725279 |
136 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.72688385 |
137 | AR_25329375_ChIP-Seq_VCAP_Human | 0.72483890 |
138 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.71908588 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.11731726 |
2 | MP0002837_dystrophic_cardiac_calcinosis | 3.35764253 |
3 | MP0003646_muscle_fatigue | 3.26323232 |
4 | MP0003880_abnormal_central_pattern | 3.18980209 |
5 | MP0000751_myopathy | 3.18534254 |
6 | MP0004270_analgesia | 3.16589229 |
7 | MP0003635_abnormal_synaptic_transmissio | 2.98128054 |
8 | MP0002822_catalepsy | 2.89954693 |
9 | MP0005451_abnormal_body_composition | 2.50510430 |
10 | MP0003123_paternal_imprinting | 2.43288390 |
11 | MP0004145_abnormal_muscle_electrophysio | 2.37908453 |
12 | MP0004130_abnormal_muscle_cell | 2.37581999 |
13 | MP0009745_abnormal_behavioral_response | 2.36403890 |
14 | MP0005085_abnormal_gallbladder_physiolo | 2.31274515 |
15 | MP0002139_abnormal_hepatobiliary_system | 2.28048082 |
16 | MP0003705_abnormal_hypodermis_morpholog | 2.28024600 |
17 | MP0002063_abnormal_learning/memory/cond | 2.27147626 |
18 | MP0003122_maternal_imprinting | 2.22557101 |
19 | MP0001968_abnormal_touch/_nociception | 2.20380918 |
20 | MP0002064_seizures | 2.19963361 |
21 | MP0002089_abnormal_postnatal_growth/wei | 2.19254832 |
22 | MP0003172_abnormal_lysosome_physiology | 2.17336973 |
23 | MP0005409_darkened_coat_color | 2.16997286 |
24 | MP0003329_amyloid_beta_deposits | 2.13009715 |
25 | MP0000749_muscle_degeneration | 2.12136310 |
26 | MP0000747_muscle_weakness | 1.98564674 |
27 | MP0004036_abnormal_muscle_relaxation | 1.98165760 |
28 | MP0004215_abnormal_myocardial_fiber | 1.97320765 |
29 | MP0009046_muscle_twitch | 1.96404965 |
30 | MP0005365_abnormal_bile_salt | 1.94679898 |
31 | MP0002272_abnormal_nervous_system | 1.91784270 |
32 | MP0005058_abnormal_lysosome_morphology | 1.86893811 |
33 | MP0002735_abnormal_chemical_nociception | 1.86124261 |
34 | MP0002734_abnormal_mechanical_nocicepti | 1.84906997 |
35 | MP0005360_urolithiasis | 1.83572118 |
36 | MP0000003_abnormal_adipose_tissue | 1.81387432 |
37 | MP0002572_abnormal_emotion/affect_behav | 1.76750061 |
38 | MP0002736_abnormal_nociception_after | 1.75628302 |
39 | MP0002909_abnormal_adrenal_gland | 1.69681538 |
40 | MP0001486_abnormal_startle_reflex | 1.69578681 |
41 | MP0004858_abnormal_nervous_system | 1.69373090 |
42 | MP0005423_abnormal_somatic_nervous | 1.68581004 |
43 | MP0005083_abnormal_biliary_tract | 1.68371237 |
44 | MP0000678_abnormal_parathyroid_gland | 1.65210343 |
45 | MP0002269_muscular_atrophy | 1.61239058 |
46 | MP0004084_abnormal_cardiac_muscle | 1.58960145 |
47 | MP0009780_abnormal_chondrocyte_physiolo | 1.54262944 |
48 | MP0004087_abnormal_muscle_fiber | 1.52171661 |
49 | MP0005330_cardiomyopathy | 1.51719077 |
50 | MP0002733_abnormal_thermal_nociception | 1.50149203 |
51 | MP0002249_abnormal_larynx_morphology | 1.49812553 |
52 | MP0001440_abnormal_grooming_behavior | 1.49422583 |
53 | MP0000566_synostosis | 1.45843227 |
54 | MP0001348_abnormal_lacrimal_gland | 1.45598107 |
55 | MP0008569_lethality_at_weaning | 1.44748212 |
56 | MP0005375_adipose_tissue_phenotype | 1.44154520 |
57 | MP0005620_abnormal_muscle_contractility | 1.40298395 |
58 | MP0001970_abnormal_pain_threshold | 1.40256788 |
59 | MP0001501_abnormal_sleep_pattern | 1.39023930 |
60 | MP0003137_abnormal_impulse_conducting | 1.38491630 |
61 | MP0003868_abnormal_feces_composition | 1.37938306 |
62 | MP0008875_abnormal_xenobiotic_pharmacok | 1.37806852 |
63 | MP0010329_abnormal_lipoprotein_level | 1.36963860 |
64 | MP0002106_abnormal_muscle_physiology | 1.35613234 |
65 | MP0004924_abnormal_behavior | 1.34866541 |
66 | MP0005386_behavior/neurological_phenoty | 1.34866541 |
67 | MP0006036_abnormal_mitochondrial_physio | 1.33915629 |
68 | MP0002067_abnormal_sensory_capabilities | 1.32567323 |
69 | MP0002971_abnormal_brown_adipose | 1.31202004 |
70 | MP0003806_abnormal_nucleotide_metabolis | 1.30622503 |
71 | MP0004233_abnormal_muscle_weight | 1.30121001 |
72 | MP0001502_abnormal_circadian_rhythm | 1.29978729 |
73 | MP0000759_abnormal_skeletal_muscle | 1.29341435 |
74 | MP0004811_abnormal_neuron_physiology | 1.27181776 |
75 | MP0000920_abnormal_myelination | 1.24546528 |
76 | MP0004085_abnormal_heartbeat | 1.23517360 |
77 | MP0009840_abnormal_foam_cell | 1.23346248 |
78 | MP0005535_abnormal_body_temperature | 1.21855486 |
79 | MP0003633_abnormal_nervous_system | 1.20318199 |
80 | MP0004484_altered_response_of | 1.18372626 |
81 | MP0000955_abnormal_spinal_cord | 1.17466153 |
82 | MP0005332_abnormal_amino_acid | 1.16009747 |
83 | MP0008961_abnormal_basal_metabolism | 1.15762865 |
84 | MP0006276_abnormal_autonomic_nervous | 1.15624958 |
85 | MP0003879_abnormal_hair_cell | 1.14391952 |
86 | MP0004885_abnormal_endolymph | 1.13679903 |
87 | MP0000604_amyloidosis | 1.13422815 |
88 | MP0010368_abnormal_lymphatic_system | 1.12737152 |
89 | MP0002108_abnormal_muscle_morphology | 1.12213987 |
90 | MP0002972_abnormal_cardiac_muscle | 1.12190903 |
91 | MP0005369_muscle_phenotype | 1.11601261 |
92 | MP0002066_abnormal_motor_capabilities/c | 1.11509928 |
93 | MP0008874_decreased_physiological_sensi | 1.10418785 |
94 | MP0005167_abnormal_blood-brain_barrier | 1.09631718 |
95 | MP0002118_abnormal_lipid_homeostasis | 1.09153159 |
96 | MP0002184_abnormal_innervation | 1.08673813 |
97 | MP0001849_ear_inflammation | 1.07108243 |
98 | MP0008260_abnormal_autophagy | 1.06755967 |
99 | MP0004142_abnormal_muscle_tone | 1.05474936 |
100 | MP0008438_abnormal_cutaneous_collagen | 1.05450075 |
101 | MP0005076_abnormal_cell_differentiation | 1.04591929 |
102 | MP0004510_myositis | 1.03042790 |
103 | MP0006035_abnormal_mitochondrial_morpho | 1.01601072 |
104 | MP0003634_abnormal_glial_cell | 0.99543531 |
105 | MP0002557_abnormal_social/conspecific_i | 0.99460936 |
106 | MP0005666_abnormal_adipose_tissue | 0.96546484 |
107 | MP0005670_abnormal_white_adipose | 0.96217998 |
108 | MP0000750_abnormal_muscle_regeneration | 0.94195006 |
109 | MP0006138_congestive_heart_failure | 0.93990832 |
110 | MP0008872_abnormal_physiological_respon | 0.93960434 |
111 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92231936 |
112 | MP0003631_nervous_system_phenotype | 0.92031566 |
113 | MP0003690_abnormal_glial_cell | 0.88846128 |
114 | MP0002882_abnormal_neuron_morphology | 0.87807440 |
115 | MP0001529_abnormal_vocalization | 0.87483648 |
116 | MP0001544_abnormal_cardiovascular_syste | 0.87359882 |
117 | MP0005385_cardiovascular_system_phenoty | 0.87359882 |
118 | MP0003075_altered_response_to | 0.86607327 |
119 | MP0000013_abnormal_adipose_tissue | 0.85007689 |
120 | MP0004185_abnormal_adipocyte_glucose | 0.83855136 |
121 | MP0010630_abnormal_cardiac_muscle | 0.82612347 |
122 | MP0000778_abnormal_nervous_system | 0.81615563 |
123 | MP0002229_neurodegeneration | 0.81466075 |
124 | MP0008775_abnormal_heart_ventricle | 0.80207888 |
125 | MP0001666_abnormal_nutrient_absorption | 0.79808866 |
126 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78317688 |
127 | MP0002078_abnormal_glucose_homeostasis | 0.78075350 |
128 | MP0003191_abnormal_cellular_cholesterol | 0.77738860 |
129 | MP0005448_abnormal_energy_balance | 0.71160927 |
130 | MP0003045_fibrosis | 0.71137646 |
131 | MP0002896_abnormal_bone_mineralization | 0.65702178 |
132 | MP0003632_abnormal_nervous_system | 0.65480788 |
133 | MP0001958_emphysema | 0.64516636 |
134 | MP0000681_abnormal_thyroid_gland | 0.63266348 |
135 | MP0000609_abnormal_liver_physiology | 0.63250480 |
136 | MP0000733_abnormal_muscle_development | 0.62427885 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myokymia (HP:0002411) | 5.18958077 |
2 | Exercise-induced myalgia (HP:0003738) | 4.90583059 |
3 | Focal motor seizures (HP:0011153) | 4.47446519 |
4 | Sudden death (HP:0001699) | 3.77893120 |
5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.72126658 |
6 | Bundle branch block (HP:0011710) | 3.67040559 |
7 | Calf muscle hypertrophy (HP:0008981) | 3.66658528 |
8 | Exercise-induced muscle cramps (HP:0003710) | 3.58177487 |
9 | Myoglobinuria (HP:0002913) | 3.54888421 |
10 | Obstructive sleep apnea (HP:0002870) | 3.51062469 |
11 | Visual hallucinations (HP:0002367) | 3.48534416 |
12 | Focal seizures (HP:0007359) | 3.32514078 |
13 | Ventricular fibrillation (HP:0001663) | 3.31084354 |
14 | Hyporeflexia of lower limbs (HP:0002600) | 3.29170921 |
15 | Myotonia (HP:0002486) | 3.06887195 |
16 | Difficulty running (HP:0009046) | 3.06523027 |
17 | Complement deficiency (HP:0004431) | 3.01809481 |
18 | Neurofibrillary tangles (HP:0002185) | 2.92300203 |
19 | Joint hemorrhage (HP:0005261) | 2.91887770 |
20 | Muscle fiber splitting (HP:0003555) | 2.89806657 |
21 | Cerebral aneurysm (HP:0004944) | 2.89062951 |
22 | Heart block (HP:0012722) | 2.87462684 |
23 | Prolonged partial thromboplastin time (HP:0003645) | 2.83668634 |
24 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.83471474 |
25 | Ankle clonus (HP:0011448) | 2.82314701 |
26 | Protrusio acetabuli (HP:0003179) | 2.81578748 |
27 | Atrioventricular block (HP:0001678) | 2.80728546 |
28 | Myopathic facies (HP:0002058) | 2.78664084 |
29 | EMG: myopathic abnormalities (HP:0003458) | 2.77811245 |
30 | Poor eye contact (HP:0000817) | 2.74682032 |
31 | Ketosis (HP:0001946) | 2.74177893 |
32 | Abnormal social behavior (HP:0012433) | 2.71994507 |
33 | Impaired social interactions (HP:0000735) | 2.71994507 |
34 | Urinary urgency (HP:0000012) | 2.68927153 |
35 | Abnormality of the lower motor neuron (HP:0002366) | 2.67971119 |
36 | Generalized tonic-clonic seizures (HP:0002069) | 2.67946925 |
37 | Abnormality of the calf musculature (HP:0001430) | 2.67229780 |
38 | Action tremor (HP:0002345) | 2.66947950 |
39 | Hypercholesterolemia (HP:0003124) | 2.64323825 |
40 | Supranuclear gaze palsy (HP:0000605) | 2.62683592 |
41 | Abnormal atrioventricular conduction (HP:0005150) | 2.60241897 |
42 | Cerebral inclusion bodies (HP:0100314) | 2.58431171 |
43 | Pheochromocytoma (HP:0002666) | 2.55630393 |
44 | Muscle stiffness (HP:0003552) | 2.55196154 |
45 | Abnormality of complement system (HP:0005339) | 2.52700164 |
46 | Hemorrhage of the eye (HP:0011885) | 2.52441146 |
47 | Abnormality of the Achilles tendon (HP:0005109) | 2.51723080 |
48 | Muscle fiber inclusion bodies (HP:0100299) | 2.50000907 |
49 | Syncope (HP:0001279) | 2.48446609 |
50 | Ketoacidosis (HP:0001993) | 2.48167422 |
51 | Atonic seizures (HP:0010819) | 2.48127242 |
52 | Deep venous thrombosis (HP:0002625) | 2.47619742 |
53 | Absence seizures (HP:0002121) | 2.41726394 |
54 | Gout (HP:0001997) | 2.41573431 |
55 | Achilles tendon contracture (HP:0001771) | 2.41566040 |
56 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.41181263 |
57 | Hyperlipoproteinemia (HP:0010980) | 2.39161468 |
58 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.38591366 |
59 | Depression (HP:0000716) | 2.38101002 |
60 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.37245734 |
61 | Hyperammonemia (HP:0001987) | 2.37031534 |
62 | Bronchomalacia (HP:0002780) | 2.36591383 |
63 | Difficulty climbing stairs (HP:0003551) | 2.36255046 |
64 | Dysmetric saccades (HP:0000641) | 2.35558545 |
65 | Postural instability (HP:0002172) | 2.34883818 |
66 | Akinesia (HP:0002304) | 2.34182943 |
67 | Anxiety (HP:0000739) | 2.32964864 |
68 | Insidious onset (HP:0003587) | 2.32119467 |
69 | Termporal pattern (HP:0011008) | 2.32119467 |
70 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.31470239 |
71 | Increased variability in muscle fiber diameter (HP:0003557) | 2.31449828 |
72 | Stridor (HP:0010307) | 2.30795538 |
73 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.30223673 |
74 | Hyperglycinemia (HP:0002154) | 2.28135650 |
75 | Ventricular arrhythmia (HP:0004308) | 2.26994202 |
76 | Prolonged QT interval (HP:0001657) | 2.25941983 |
77 | Status epilepticus (HP:0002133) | 2.25241635 |
78 | Hyperglycinuria (HP:0003108) | 2.24855484 |
79 | Round ear (HP:0100830) | 2.24641599 |
80 | Atrial fibrillation (HP:0005110) | 2.24209682 |
81 | Rhabdomyolysis (HP:0003201) | 2.22122288 |
82 | Mitral stenosis (HP:0001718) | 2.21922125 |
83 | Abnormal EKG (HP:0003115) | 2.20785337 |
84 | Abnormality of glycine metabolism (HP:0010895) | 2.18628318 |
85 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.18628318 |
86 | Hypercortisolism (HP:0001578) | 2.18473462 |
87 | Neuroendocrine neoplasm (HP:0100634) | 2.18018403 |
88 | Xanthomatosis (HP:0000991) | 2.17083783 |
89 | Dysdiadochokinesis (HP:0002075) | 2.16790042 |
90 | Febrile seizures (HP:0002373) | 2.16758783 |
91 | Primary atrial arrhythmia (HP:0001692) | 2.16728980 |
92 | Dialeptic seizures (HP:0011146) | 2.15813650 |
93 | Dysmetria (HP:0001310) | 2.15059754 |
94 | Epileptic encephalopathy (HP:0200134) | 2.15030513 |
95 | Distal upper limb amyotrophy (HP:0007149) | 2.13725822 |
96 | Upper limb amyotrophy (HP:0009129) | 2.13725822 |
97 | Spastic gait (HP:0002064) | 2.11958160 |
98 | Torticollis (HP:0000473) | 2.11622910 |
99 | Foot dorsiflexor weakness (HP:0009027) | 2.10835915 |
100 | Spinal rigidity (HP:0003306) | 2.08676377 |
101 | Abnormality of binocular vision (HP:0011514) | 2.08575989 |
102 | Diplopia (HP:0000651) | 2.08575989 |
103 | Hypobetalipoproteinemia (HP:0003563) | 2.07426448 |
104 | Supraventricular tachycardia (HP:0004755) | 2.06913596 |
105 | Ventricular tachycardia (HP:0004756) | 2.05302690 |
106 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.04907161 |
107 | Nemaline bodies (HP:0003798) | 2.02413703 |
108 | Asymmetric septal hypertrophy (HP:0001670) | 2.02384233 |
109 | Distal arthrogryposis (HP:0005684) | 2.01056818 |
110 | Focal dystonia (HP:0004373) | 2.00166887 |
111 | Supraventricular arrhythmia (HP:0005115) | 2.00060816 |
112 | Scanning speech (HP:0002168) | 1.99133712 |
113 | EMG: neuropathic changes (HP:0003445) | 1.96277196 |
114 | Impaired vibratory sensation (HP:0002495) | 1.96155348 |
115 | Rapidly progressive (HP:0003678) | 1.95107005 |
116 | Abnormality of the foot musculature (HP:0001436) | 1.94454894 |
117 | Areflexia of lower limbs (HP:0002522) | 1.94294090 |
118 | Hypoalphalipoproteinemia (HP:0003233) | 1.93838161 |
119 | Limb-girdle muscle atrophy (HP:0003797) | 1.93641644 |
120 | Progressive cerebellar ataxia (HP:0002073) | 1.93633342 |
121 | Distal lower limb amyotrophy (HP:0008944) | 1.93380149 |
122 | Cholelithiasis (HP:0001081) | 1.92754136 |
123 | Palpitations (HP:0001962) | 1.91641166 |
124 | Craniofacial dystonia (HP:0012179) | 1.90176226 |
125 | Reticulocytosis (HP:0001923) | 1.90152845 |
126 | Annular pancreas (HP:0001734) | 1.89481431 |
127 | Truncal ataxia (HP:0002078) | 1.88652202 |
128 | Bulbar palsy (HP:0001283) | 1.88648623 |
129 | Subaortic stenosis (HP:0001682) | 1.88524871 |
130 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.88524871 |
131 | Hyperacusis (HP:0010780) | 1.88449722 |
132 | Athetosis (HP:0002305) | 1.87888168 |
133 | Neonatal onset (HP:0003623) | 1.87861550 |
134 | Glomerulonephritis (HP:0000099) | 1.87774514 |
135 | Type 1 muscle fiber predominance (HP:0003803) | 1.87064175 |
136 | Increased connective tissue (HP:0009025) | 1.85935086 |
137 | Rigidity (HP:0002063) | 1.84035514 |
138 | Ulnar deviation of the wrist (HP:0003049) | 1.83315441 |
139 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.82308317 |
140 | Insomnia (HP:0100785) | 1.81295628 |
141 | Lower limb amyotrophy (HP:0007210) | 1.80894140 |
142 | Growth hormone excess (HP:0000845) | 1.77881180 |
143 | Skin nodule (HP:0200036) | 1.77730240 |
144 | Thin bony cortex (HP:0002753) | 1.76540666 |
145 | Shallow orbits (HP:0000586) | 1.76525737 |
146 | Distal lower limb muscle weakness (HP:0009053) | 1.76170475 |
147 | Systemic lupus erythematosus (HP:0002725) | 1.75796286 |
148 | Neuronal loss in central nervous system (HP:0002529) | 1.73414659 |
149 | Flat acetabular roof (HP:0003180) | 1.71015046 |
150 | Small epiphyses (HP:0010585) | 1.68495980 |
151 | Spinal canal stenosis (HP:0003416) | 1.68161896 |
152 | Abnormality of carpal bone ossification (HP:0006257) | 1.67755713 |
153 | Impaired pain sensation (HP:0007328) | 1.67371409 |
154 | Abnormality of pain sensation (HP:0010832) | 1.67371409 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 3.76062095 |
2 | MAP3K9 | 3.44227482 |
3 | NTRK3 | 3.42543814 |
4 | PHKG2 | 2.87625984 |
5 | PHKG1 | 2.87625984 |
6 | FGFR4 | 2.72154011 |
7 | ICK | 2.68906037 |
8 | KSR2 | 2.52528315 |
9 | EEF2K | 2.43895115 |
10 | MAP2K4 | 2.41236098 |
11 | DAPK2 | 2.39478885 |
12 | SIK1 | 2.36606091 |
13 | MAP3K4 | 2.34306933 |
14 | TRIB3 | 2.26483910 |
15 | MINK1 | 2.25129236 |
16 | BCKDK | 2.18365318 |
17 | PAK6 | 2.16529991 |
18 | PRKD3 | 2.09563346 |
19 | MARK1 | 2.06417428 |
20 | PINK1 | 2.02663711 |
21 | LMTK2 | 1.99499280 |
22 | NTRK1 | 1.87692340 |
23 | TTN | 1.82621731 |
24 | CAMKK1 | 1.80949218 |
25 | STK38 | 1.69109057 |
26 | MUSK | 1.57106616 |
27 | OBSCN | 1.55389550 |
28 | FGFR3 | 1.55119240 |
29 | NEK1 | 1.54966576 |
30 | MAP2K7 | 1.52754252 |
31 | ERN1 | 1.51511427 |
32 | CDK12 | 1.45263319 |
33 | PDK4 | 1.41394084 |
34 | PDK3 | 1.41394084 |
35 | SMG1 | 1.39376743 |
36 | PDGFRA | 1.36356048 |
37 | LATS2 | 1.30372713 |
38 | PKN2 | 1.28227173 |
39 | TAOK1 | 1.27104042 |
40 | NTRK2 | 1.23619826 |
41 | MAP3K7 | 1.23224934 |
42 | CDK5 | 1.18591867 |
43 | KSR1 | 1.11950133 |
44 | ARAF | 1.07278892 |
45 | NME1 | 1.07196296 |
46 | WNK1 | 1.04875481 |
47 | RET | 1.04317737 |
48 | DAPK1 | 1.01227270 |
49 | PRKCG | 0.99540583 |
50 | PDPK1 | 0.98371253 |
51 | CDK19 | 0.97869338 |
52 | GRK5 | 0.97201648 |
53 | MAP3K2 | 0.97110987 |
54 | MAPK12 | 0.96560783 |
55 | MAPK11 | 0.94930761 |
56 | TYRO3 | 0.92475156 |
57 | TNIK | 0.90633675 |
58 | SIK2 | 0.89944547 |
59 | MAP3K13 | 0.89769911 |
60 | PDK1 | 0.89255946 |
61 | CAMK1 | 0.87467432 |
62 | MAP3K12 | 0.86247030 |
63 | PRKCH | 0.85093922 |
64 | STK11 | 0.85068757 |
65 | DDR2 | 0.84368317 |
66 | MTOR | 0.83487616 |
67 | MAP3K1 | 0.80662310 |
68 | PAK3 | 0.80546225 |
69 | PRPF4B | 0.76433282 |
70 | PRKD2 | 0.75729779 |
71 | CAMK2A | 0.75432906 |
72 | MAP3K6 | 0.75025495 |
73 | CAMKK2 | 0.73517388 |
74 | FES | 0.73173295 |
75 | ALK | 0.72814313 |
76 | RIPK1 | 0.72309111 |
77 | PTK2 | 0.71492402 |
78 | MAP2K3 | 0.71471499 |
79 | TAOK2 | 0.71433157 |
80 | DMPK | 0.70255963 |
81 | MAP2K6 | 0.69647685 |
82 | RIPK4 | 0.68753331 |
83 | SGK223 | 0.68410006 |
84 | SGK494 | 0.68410006 |
85 | UHMK1 | 0.67457663 |
86 | PDK2 | 0.67042599 |
87 | CAMK2G | 0.66047952 |
88 | DYRK1B | 0.64024501 |
89 | SGK3 | 0.63750701 |
90 | PRKAA2 | 0.62495243 |
91 | TNK2 | 0.62461755 |
92 | CAMK4 | 0.61933711 |
93 | EPHA2 | 0.61268719 |
94 | MAPK13 | 0.60986258 |
95 | MAP2K1 | 0.60393105 |
96 | BMX | 0.59851065 |
97 | RAF1 | 0.57604053 |
98 | NEK6 | 0.57469974 |
99 | MAPK10 | 0.57414453 |
100 | PTK6 | 0.56748643 |
101 | PRKAA1 | 0.55939176 |
102 | MARK2 | 0.54374026 |
103 | CDK15 | 0.54289921 |
104 | FGFR2 | 0.51786633 |
105 | RPS6KA3 | 0.51710726 |
106 | RPS6KB1 | 0.51538912 |
107 | CDK18 | 0.50972934 |
108 | DAPK3 | 0.50576652 |
109 | PRKCZ | 0.50198426 |
110 | CAMK2D | 0.50052878 |
111 | CDK14 | 0.49747339 |
112 | PRKD1 | 0.49654972 |
113 | SGK1 | 0.48664127 |
114 | PRKG2 | 0.48207718 |
115 | CDK11A | 0.45150505 |
116 | MAP3K11 | 0.44773284 |
117 | PDGFRB | 0.44352634 |
118 | PTK2B | 0.43819290 |
119 | CDC42BPA | 0.41540715 |
120 | SGK2 | 0.40702412 |
121 | CAMK2B | 0.40644622 |
122 | HIPK2 | 0.40592571 |
123 | PRKACB | 0.38992740 |
124 | PRKACG | 0.38975961 |
125 | CAMK1G | 0.38574740 |
126 | IRAK3 | 0.38554140 |
127 | MAPKAPK3 | 0.37966824 |
128 | RPS6KA2 | 0.36871159 |
129 | PIK3CA | 0.36539843 |
130 | PNCK | 0.36204418 |
131 | CSNK1G2 | 0.35587560 |
132 | MAPK8 | 0.35140962 |
133 | MAPK15 | 0.34882490 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.37278488 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.13198271 |
3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.40298464 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.36469837 |
5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.16326992 |
6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.10851721 |
7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.90718690 |
8 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78556342 |
9 | Olfactory transduction_Homo sapiens_hsa04740 | 1.76984491 |
10 | Nicotine addiction_Homo sapiens_hsa05033 | 1.74911386 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.71725752 |
12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.71622537 |
13 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71398037 |
14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.67284989 |
15 | Circadian entrainment_Homo sapiens_hsa04713 | 1.66808498 |
16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.64900331 |
17 | GABAergic synapse_Homo sapiens_hsa04727 | 1.63056623 |
18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.62831241 |
19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.62675780 |
20 | Long-term potentiation_Homo sapiens_hsa04720 | 1.62623268 |
21 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.56366863 |
22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55968858 |
23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.50726965 |
24 | Prion diseases_Homo sapiens_hsa05020 | 1.48782973 |
25 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.46946931 |
26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.40556472 |
27 | Insulin secretion_Homo sapiens_hsa04911 | 1.38904748 |
28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38772824 |
29 | Salivary secretion_Homo sapiens_hsa04970 | 1.36614556 |
30 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.35877589 |
31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.33508545 |
32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.32271332 |
33 | Morphine addiction_Homo sapiens_hsa05032 | 1.30340561 |
34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.30247538 |
35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.27861741 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.25142081 |
37 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.24845966 |
38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23240118 |
39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.20303902 |
40 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.17954464 |
41 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.17445181 |
42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.14679171 |
43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.14551554 |
44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.12938393 |
45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.08575323 |
46 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.07713638 |
47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07475042 |
48 | ABC transporters_Homo sapiens_hsa02010 | 1.05088287 |
49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.04270217 |
50 | Renin secretion_Homo sapiens_hsa04924 | 1.02420831 |
51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.00137891 |
52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.99473823 |
53 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.99146256 |
54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.98706183 |
55 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94928776 |
56 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.94746326 |
57 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.92685115 |
58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.92005958 |
59 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.89324955 |
60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.88979905 |
61 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.85507514 |
62 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.85071846 |
63 | Taste transduction_Homo sapiens_hsa04742 | 0.80881080 |
64 | Long-term depression_Homo sapiens_hsa04730 | 0.79430710 |
65 | Gap junction_Homo sapiens_hsa04540 | 0.79405325 |
66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79216479 |
67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.77939427 |
68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.76910284 |
69 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.76702264 |
70 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76676368 |
71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76497153 |
72 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.75639746 |
73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.75331893 |
74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.75057796 |
75 | Cocaine addiction_Homo sapiens_hsa05030 | 0.75014451 |
76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.73627868 |
77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73236248 |
78 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73178877 |
79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72870487 |
80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72302576 |
81 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.71612538 |
82 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70586719 |
83 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69792145 |
84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68868003 |
85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.68486179 |
86 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67730305 |
87 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.66718148 |
88 | Peroxisome_Homo sapiens_hsa04146 | 0.65733067 |
89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65619786 |
90 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64700967 |
91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64322201 |
92 | Glioma_Homo sapiens_hsa05214 | 0.63584705 |
93 | Insulin resistance_Homo sapiens_hsa04931 | 0.63357295 |
94 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62932466 |
95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62438492 |
96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61727730 |
97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61551950 |
98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60506504 |
99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.59173462 |
100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59039464 |
101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58343555 |
102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58291837 |
103 | Focal adhesion_Homo sapiens_hsa04510 | 0.57566080 |
104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.57479622 |
105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56704250 |
106 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.55785362 |
107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55719815 |
108 | Lysine degradation_Homo sapiens_hsa00310 | 0.55672470 |
109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55669020 |
110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55395502 |
111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54812488 |
112 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.54479154 |
113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54144921 |
114 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53933123 |
115 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53286670 |
116 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52935429 |
117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52135681 |
118 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51297867 |
119 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.50859984 |
120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48922870 |
121 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48920217 |
122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48364713 |
123 | Melanogenesis_Homo sapiens_hsa04916 | 0.47994289 |
124 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47953990 |
125 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46895214 |
126 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46057709 |
127 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45943396 |